Barcelona, Spain

Maria Gallo

This inventor holds 1 USPTO granted patent. Top assignees: Faculdade De Medicina Da Universidade De Lisboa, Instituto De Medicina Molecular Joao Lobo Antunes, Pompeu Fabra University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Gallo. Retrieved from https://idiyas.com/inventor/maria-gallo-azoyvnb9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Gallo: Innovator in Peptide Compounds

Introduction

Maria Gallo is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of medicinal chemistry, particularly in the development of peptide compounds aimed at reducing the side effects of CB1 receptor agonists. Her innovative work has the potential to impact therapeutic practices significantly.

Latest Patents

Maria Gallo holds 1 patent for her invention titled "Peptide compounds for reducing side effects of CB1 receptor agonists." This patent relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, along with processes for their obtention and therapeutic indications. Her research addresses critical challenges in pharmacology, providing new avenues for treatment.

Career Highlights

Throughout her career, Maria has been associated with esteemed institutions such as the University of Barcelona and Universitat Pompeu Fabra. Her work in these academic environments has allowed her to explore innovative solutions in the field of drug development.

Collaborations

Maria has collaborated with notable colleagues, including Vicent Casadó Burillo and Estefania Moreno Guillen. These partnerships have enriched her research and contributed to the advancement of her projects.

Conclusion

Maria Gallo's contributions to the field of peptide compounds exemplify her dedication to innovation in medicinal chemistry. Her work not only enhances our understanding of drug interactions but also paves the way for future therapeutic advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…